Shin Nippon Biomedical Laboratories (SNBL)
Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.
4 contract research organizations in our directory list both Repeat-Dose Toxicity and Cynomolgus monkey among their capabilities, across 3 countries. 4 report GLP capability and 1 reports AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 4 CROs. Order rotates daily so no lab is permanently listed first.
Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.
Large China-based nonclinical CRO offering GLP safety assessment, pharmacology, pharmacokinetics and bioanalysis, with operations in China and the United States.
Korean nonhuman primate CRO in the Biotoxtech group with GLP repeat-dose toxicity and cardiovascular safety pharmacology in NHPs, plus NHP inhalation studies.
NeuroBridge Biotechnology is a specialized preclinical research organization based in Guangzhou, China, focused on non-human primate (NHP) and pig disease models and exploratory non-GLP translational studies. We support…